Drugs & medicalClass II

Teva Pharmaceuticals USA Inc recalls Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL…

Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.

Read the official notice →
Date
2023-03-22
Country
United States
Brand
Teva Pharmaceuticals
Product
Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL (0.085 fl…
Classification
Class II
Units
Nationwide in the U.S.A.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Teva Pharmaceuticals recalls

  1. 2023-07-19
  2. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ…

    Failed Moisture Limits: Water (moisture) content above the approved product specifications.

    FDA · DrugTeva Pharmaceuticals USA IncProduct was distributed to 3 wholesalers/distributors who further distributed…Official notice →
  3. 2023-05-31
  4. US
  5. 2023-04-12
  6. US
    Drugs & medicalClass III

    Teva Pharmaceuticals USA Inc recalls Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva…

    Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.

    FDA · DrugTeva Pharmaceuticals USA IncUSA NationwideOfficial notice →
  7. 2023-03-15
  8. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, RX only, Manufactured by: Actavis Laboratories FL,…

    CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

    FDA · DrugTeva Pharmaceuticals USA IncCAOfficial notice →
  9. 2022-09-21
  10. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a…

    Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

    FDA · DrugTeva Pharmaceuticals USA IncNationwide in the US.Official notice →
  11. 2022-09-07
  12. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA…

    CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

    FDA · DrugTeva Pharmaceuticals USA IncNationwide within the United StatesOfficial notice →
All 44 Teva Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2023-03-22
  2. US
    Drugs & medicalClass II

    Becton Dickinson & Company recalls BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes…

    Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

    FDA · DeviceBecton Dickinson & CompanyWorldwide distribution - US Nationwide and the countries of Chile, Colombia,…Official notice →
  3. US
    Drugs & medicalClass II

    OMM Imports, Inc. dba Zero Gravity recalls Recreo Hair Growth Laser Comb

    The firm distributed the laser products without affixing the warning, aperture, certification, and identification labels. In addition, the firm failed to provide safety information, reproductions and locations of the…

    FDA · DeviceOMM Imports, Inc. dba Zero GravityWorldwide and Nationwide including DC and Puerto RicoOfficial notice →
  4. US
    Drugs & medicalClass I

    Avanos Medical, Inc. recalls BALLARD* ACCESS Closed Suction System for Neonates/Pediatrics, Elbow Manifold.

    Potential for product manifold to crack during use on patients, possibly causing leaks in the respiratory circuit and can lead to the patient receiving inadequate ventilation.

    FDA · DeviceAvanos Medical, Inc.US Nationwide distribution in the state of Oklahoma.Official notice →
  5. US
    Drugs & medicalClass III

    Zydus Pharmaceuticals (USA) Inc recalls Colchicine Tablets, USP 0.6 mg, Rx Only, a) 30 tablets per bottle, NDC 16714-0039-01, b) 100 tablets per bottle, NDC…

    Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine.

    FDA · DrugZydus Pharmaceuticals (USA) IncAZ, OH, MS.Official notice →
  6. US
    Drugs & medicalClass III

    AVEVA Drug Delivery Systems, Inc. recalls Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only,…

    Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.

    FDA · DrugAVEVA Drug Delivery Systems, Inc.NationwideOfficial notice →
  7. US
    Drugs & medicalClass III

    Padagis US LLC recalls Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx Only, Manufactured by…

    Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.

    FDA · DrugPadagis US LLCNationwide in the USAOfficial notice →
See all drugs & medical recalls →